Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Bionano Genomics, Inc. (BNGO) had Return on Assets of -146.10% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$30.78M |
|
$-112.02M |
|
$30.40M |
|
$0.38M |
|
$134.76M |
|
$-103.98M |
|
$-8.00M |
|
$-111.98M |
|
$-111.98M |
|
$-112.02M |
|
$-112.02M |
|
$-112.02M |
|
$-112.02M |
|
$-103.98M |
|
$-70.52M |
|
1.27M |
|
1.27M |
|
$-88.13 |
|
$-88.13 |
|
| Balance Sheet Financials | |
$39.49M |
|
$19.22M |
|
$37.18M |
|
$76.67M |
|
$37.34M |
|
$3.54M |
|
$3.95M |
|
$41.30M |
|
$35.38M |
|
$25.67M |
|
$35.38M |
|
1.86M |
|
| Cash Flow Statement Financials | |
$-68.92M |
|
$73.84M |
|
$-13.69M |
|
$18.35M |
|
$9.57M |
|
$-8.78M |
|
$9.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
0.09 |
|
0.68 |
|
1.23% |
|
-337.87% |
|
-337.87% |
|
-229.15% |
|
-363.87% |
|
-363.98% |
|
$-69.03M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
2.73 |
|
6.48 |
|
56.36 |
|
-316.66% |
|
-436.37% |
|
|
Return on Assets |
-146.10% |
-287.86% |
|
$18.97 |
|
$-54.31 |
|
$-54.23 |
|